PAR-1 antagonists (Tasly Pharmaceutical Group)

N/A

Report date: 2025/03/20 09:54:50
NME

Base Information

Drug NamePAR-1 antagonists (Tasly Pharmaceutical Group)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtease-activated receptor-1 antagonists
TargetsProtease-activated receptor-1
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTianjin Tasly Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Tasly Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A